ANALYSIS OF THE QUALITY OF LIFE OF PATIENTS WITH INOPERABLE LUNG CANCER DURING RADIOTHERAPY AND PHOTODYNAMIC THERAPY
Yu. A. Ragulin,
G. V. Afonin,
E. E. Beketov,
V. S. Usachev,
V. N. Kapinus,
E. I. Smolenov,
A. A. Prigorodov,
M. A. Kaplan,
I. A. Gulidov,
S. V. Gamayunov,
S. A. Ivanov,
A. D. Kaprin https://doi.org/10.21294/1814-4861-2019-18-6-20-30
Abstract
Aim: to analyze the quality of life of patients with locally advanced inoperable lung cancer during radiation and photodynamic therapy. material and methods. the study included 59 patients with stage II–III lung cancer. the first group (Rt) included 28 patients, who received radical radiation therapy. they completed questionnaires before starting radiotherapy and 2–3 days before the completion of radiotherapy. the second group (PDt + Rt) included 31 patients, who underwent endoscopic photodynamic therapy followed by radical radiation therapy. they were interviewed three times: before PDt, 10 days after PDt (before radiation therapy), and 2–3 days before the completion of radiation therapy. two types of questionnaires were used: patient lung cancer symptom scale (Lcss) and EuroQol questionnaire (EQ-5D-5L). Results. the student’s t test and Mann-Whitney u test showed no statistically significant differences in symptoms (except for the symptom «blood in the sputum») between two groups. Both treatment options demonstrated improvement in most items assessing symptoms. In the Rt group, no statistically significant improvements in the item assessing pain were found. In the PDt + Rt group, no significant improvements in the item assessing cough were observed. a comparison of the data of the intermediate (after PDt) and the final questionnaire allowed us to establish that the items «appetite», «fatigue», «pain» and «the impact of the disease on life» improved only after the completion of full-course therapy. the improvement in the item assessing cough was observed after PDt; however, the treatment outcomes showed a return (worsening) of the symptom to the level, which was before treatment. the comparison of the data of the intermediate (after PDt) and the final questionnaire showed the improvement of the items, such as «mobility», «self-care», «daily activities» and «anxiety/depression» after PDt; however, the treatment outcomes indicated a return (worsening) of the symptom to the level, which was observed before treatment. Conclusion. Both types of questionnaires provided important information about the patient’s condition. Lcss questionnaires seem to be preferable in terms of the possibility of using parametric criteria and, as a consequence, obtaining quantitative data on changes in the health of patients. the analysis did not allow us to make a conclusion about the difference in the final efficacy Rt and PDt + Rt in terms of subjective assessment of the health status by the patients themselves. the use of questionnaires in the PDt + Rt group showed that after PDt (before starting Rt) patients had positive changes in their health, which were observed in the Rt group after the completion of full-course therapy.
About the Authors
Yu. A. Ragulin
A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
MD, PhD, Leading Researcher, Department of Radiation Therapy and Surgery for Thoracic Tumors
4, Korolev street, Obninsk, 249036, Russia
G. V. Afonin
A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
MD, Post-graduate, Department of Radiation Therapy and Surgery for Thoracic Tumors
Researcher ID (WOS): О-3150-2017
4, Korolev street, Obninsk, 249036, Russia
E. E. Beketov
A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
PhD, Head of the Laboratory of Scientific and Methodological Development of Radiological Technology
4, Korolev street, Obninsk, 249036, Russia
V. S. Usachev
A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
MD, Researcher, Department of Radiation Therapy and Surgery for Thoracic Tumors
Author ID (Scopus): 57200716739
4, Korolev street, Obninsk, 249036, Russia
V. N. Kapinus
A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
MD, PhD, Department of Photodynamic Diagnosis and Therapy
4, Korolev street, Obninsk, 249036, Russia
E. I. Smolenov
A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
MD, Researcher, Department of Radiation Therapy and Surgery for Thoracic Tumors
4, Korolev street, Obninsk, 249036, Russia
A. A. Prigorodov
A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
MD, Department of Radiation Therapy and Surgery for Thoracic Tumors
ResearcherID (WOS): F-6211-2019
4, Korolev street, Obninsk, 249036, Russia
M. A. Kaplan
A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Head of Department of Photodynamic Diagnosis and Therapy
4, Korolev street, Obninsk, 249036, Russia
I. A. Gulidov
A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
MD, Professor, Head of Radiation Therapy Department
Researcher ID (WOS): P-6870-2018
4, Korolev street, Obninsk, 249036, Russia
S. V. Gamayunov
A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
MD, PhD, Head of Department of Radiation Therapy and Surgery for Thoracic Tumors
Researcher ID (WOS): E-4857-2014
4, Korolev street, Obninsk, 249036, Russia
S. A. Ivanov
A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
MD, Professor, Director
4, Korolev street, Obninsk, 249036, Russia
A. D. Kaprin
National Medical Research Radiological Center of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
MD, Professor, Member of the Russian Academy of Sciences, General Director
4, Korolev street, Obninsk, 249036, Russia
References
1. Kaprin A.D., Starinsky V.V., Petrova G.V. The status of cancer care in Russia in 2016. Moscow, 2017. 236 p. (in Russian).
2. Ragulin Yu.A., Kaplan M.A., Medvedev V.N. Photodynamic therapy with chlorine photosensitizers on the central lung cancer. J Thorac Oncol. 2007; 2(8) Suppl.4: S622–3. doi: 10.1097/01.JTO.0000283795.73479.af.
3. Izmailov T.R. Methods of assessing the effectiveness of radiation therapy for peripheral non-smallcell lung carcinoma and prognosis of radiation therapy complications. Russian Scientific Center of Roentgenoradiology. 2008; 8. (in Russian).
4. Zavyalov А.A., Dobrodeev А.Yu., Tuzikov S.A. Life quality in lung cancer patients undergoing combined modality treatment including intraoperative radiation therapy. Siberian Journal of Oncology. 2015; 35(3): 59–64. (in Russian).
5. Langendijk J.A., Aaronson N.K., de Jong J.M.A., ten Velde G.P.M., Muller M.J., Lamers R.J., Slotman B.J., Wouters E.F.M. Prospective Study on Quality of Life Before and After Radical Radiotherapy in Non–SmallCell Lung Cancer. J Clin Oncol. 2001; 19(8): 2123–33. doi: 10.1200/JCO.2001.19.8.2123.
6. Milošević B., Pejić D., Momčičević D., Kovačević P., Stanetić M., Dragić S. Quality of life in lung cancer patients due to treatment. Signa Vitae. 2016; 11(2): 47–50. doi: 10.22514/SV112.062016.10.
7. Burmeister B.H., Michael M., Burmeister E., Cox S., Lehman M., Wirth A., Horwood K., Sasso G., Forouzesh B., Ball D. A randomized phase II trial of two regimens of moderate dose chemoradiation therapy for patients with non-small cell lung cancer not suitable for curative therapy: Trans Tasman radiation oncology study TROG 03.07. J Thorac Oncol. 2011 Dec; 6(12): 2076–82. doi: 10.1097/JTO.0b013e31822d53a9.
8. Chu D., Nguyen J., Koo K., Zeng L., Bedard G., Lam H., Wong E., Popovic M., Chow E. An update on the quality of life measurements in lung cancer patients receiving palliative radiotherapy: a literature review. World J Oncol. 2013 Apr; 4(2): 67–73. doi: 10.4021/wjon591w.
9. Pérol M., Ciuleanu T.E., Arrieta O., Prabhash K., Syrigos K.N., Goksel T., Park K., Kowalyszyn R.D., Pikiel J., Lewanski C.R., Thomas M., Dakhil S., Kim J.H., Karaseva N., Yurasov S., Zimmermann A., Lee P., Carter G.C., Reck M., Cappuzzo F., Garon E.B. Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy. Lung Cancer. 2016 Mar; 93: 95–103. doi: 10.1016/j.lungcan.2016.01.007.
10. Kimura M., Miyajima K., Kojika M., Kono T., Kato H. Photodynamic therapy (PDT) with chemotherapy for advanced lung cancer with airway stenosis. Int J Mol Sci. 2015 Oct 23; 16(10): 25466–75. doi: 10.3390/ijms161025466.
11. Moghissi K. Role of bronchoscopic photodynamic therapy in lung cancer management. Curr Opin Pulm Med. 2004 Jul; 10(4): 256–60. doi: 10.1097/01.mcp.0000128434.57020.6a.
12. Simone C.B., Friedberg J.S., Glatstein E., Stevenson J.P., Sterman D.H., Hahn S.M., Cengel K.A. Photodynamic therapy for the treatment of non-small cell lung cancer. J Thorac Dis. 2012 Feb; 4(1): 63–75. doi: 10.3978/j.issn.2072-1439.2011.11.05.
13. Hollen P.J., Gralla R.J., Kris M.G., Eberly S.W., Cox C. Normative data and trends in quality of life from the Lung Cancer Symptom Scale (LCSS). Support Care in Cancer. 1999; 7: 140–8. doi: 10.1016/S0959-8049(05)80262-X.
14. The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990; 16(3): 199–208. doi: 10.1016/0168-8510(90)90421-9.
15. Herdman M., Gudex C., Lloyd A., Janssen M.F., Kind P., Parkin D., Bonsel G., Badia X. Development and preliminary testing of the new fivelevel version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011 Dec; 20(10): 1727–36. doi: 10.1007/s11136-011-9903-x.
16. Van Hout B., Janssen M.F., Feng Y.S., Kohlmann T., Busschbach J., Golicki D., Lloyd A., Scalone L., Kind P., Pickard A.S. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012 Jul-Aug; 15(5): 708–15. doi: 10.1016/j.jval.2012.02.008.
17. Kaprin A.D., Galkin V.N., Zhavoronkov L.P., Ivanov V.K., Ivanov S.A., Romanko Yu.S. Synthesis of basic and applied research is the basis of obtaining high-quality findings and translating them into clinical practice. Radiation and Risk. 2017; 26(2): 26–40. (in Russian).
18. Kaprin A.D., Mardinskiy Y.S., Smirnov V.P., Ivanov S.A., Kostin A.A., Polikhov S.A., Reshetov I.V., Fatianova A.S., Denisenko M.V., Epatova T.V., Korenev S.V., Tereshchenko A.V., Filonenko E.V., Gafarov M.M., Romanko Y.S. The history of radiation therapy (part I). Biomedical Photonics. 2019; 8(1): 52–62. (in Russian). doi: 10.24931/2413-9432-2019-8-1-52-62.
Review
For citations:
Ragulin Yu.A., Afonin G.V., Beketov E.E., Usachev V.S., Kapinus V.N., Smolenov E.I., Prigorodov A.A., Kaplan M.A., Gulidov I.A., Gamayunov S.V., Ivanov S.A., Kaprin A.D. ANALYSIS OF THE QUALITY OF LIFE OF PATIENTS WITH INOPERABLE LUNG CANCER DURING RADIOTHERAPY AND PHOTODYNAMIC THERAPY. Siberian journal of oncology. 2019;18(6):20-30. (In Russ.) https://doi.org/10.21294/1814-4861-2019-18-6-20-30
Views:
1097
Email this article 
